Showing results (51-60 of 90) with videos related to
Sort By:
Pageof 9
Brain : a Journal of Neurology|August 8, 2006
TGF-beta and metalloproteinases differentially suppress NKG2D ligand surface expression on malignant glioma cellsGünter Eisele, Jörg Wischhusen, Michel Mittelbronn, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 14, 2016
Clr-a: A Novel Immune-Related C-Type Lectin-like Molecule Exclusively Expressed by Mouse Gut EpitheliumEmilia Rutkowski, Stefan Leibelt, Christina Born, et al.Blood|April 26, 2003
Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemiaHelmut Rainer Salih, Holger Antropius, Friederike Gieseke, et al.Frontiers in Bioscience (Elite Edition)|May 31, 2011
CD155 is involved in NK-cell mediated lysis of human hepatoblastoma in vitroMatthias Pfeiffer, Guido Seitz, Peter Ruck, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 26, 2012
Comprehensive analysis of NKG2D ligand expression and release in leukemia: implications for NKG2D-mediated NK cell responsesJulia Hilpert, Ludger Grosse-Hovest, Frank Grünebach, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 19, 2005
Expression of toll-like receptors by human muscle cells in vitro and in vivo: TLR3 is highly expressed in inflammatory and HIV myopathies, mediates IL-8 release and up-regulation of NKG2D-ligandsBettina Schreiner, Joachim Voss, Jörg Wischhusen, et al.Cancer Research|August 5, 2008
Tumor-associated MICA is shed by ADAM proteasesInja Waldhauer, Dennis Goehlsdorf, Friederike Gieseke, et al.Anticancer Research|July 26, 2007
Soluble NKG2D ligands in hepatic autoimmune diseases and in benign diseases involved in marker metabolismStefan Holdenrieder, Peter Eichhorn, Ulrich Beuers, et al.Neoplasia (New York, N.Y.)|November 19, 2004
Downregulation and/or release of NKG2D ligands as immune evasion strategy of human neuroblastomaLizzia Raffaghello, Ignazia Prigione, Irma Airoldi, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2005
Systemic NKG2D down-regulation impairs NK and CD8 T cell responses in vivoKatrin Wiemann, Hans-Willi Mittrücker, Ute Feger, et al.Pageof 9